Quantitative Analysis of Transforming Growth Factor Beta 1 MRNA in Patients with Alcoholic Liver Disease

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2002 Apr 2

PMID 11925630

Citations 17

Authors

Wei-Xing Chen

You-Ming Li

Chao-Hui Yu

Wei-Min Cai

Min Zheng

Feng Chen

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate the expression of the transforming growth factor beta 1(TGF-beta 1) mRNA in different stages of alcoholic liver disease (ALD) and its clinical value.

Methods: One hundred and seven male alcoholics were grouped by clinical findings into four groups: alcohol abusers without liver impairment (n =22), alcoholic steatosis (n =30); alcoholic hepatitis (n=31); and alcoholic cirrhosis(n=24). Using peripheral blood mononuclear cells (PBMC) as samples the gene expression of TGF-beta 1 was examined quantitatively by reverse transcription polymerase chain reaction (RT-PCR) and dot blot. There are 34 healthy subjects served as control.

Results: The expression of TGF-beta 1 from all ALD patients was significantly greater than that in controls (1.320 +/- 1.162 vs 0.808 +/- 0.276, P<0.001). The differences of the expressions were significant between the patients from each groups (alcoholic steatosis, alcoholic hepatitis and alcoholic cirrhosis) and the controls (1.168 +/- 0.852, 1.462 +/- 1.657, 1.329 +/- 0.610 vs 0.808 +/- 0.276, P<0.050). No significant differences of TGF -beta 1 mRNA expression were observed between alcohol abusers without liver impairment and controls. The expressions in patients with alcoholic hepatitis and alcoholic cirrhosis were significantly greater than that in alcohol abusers respectively (1.462 +/- 1.657, 1.329 +/- 0.610 vs 0.841 +/- 0.706, P<0.050). No significant differences of TGF-beta 1 mRNA expression were observed between alcoholic fatty liver men and alcohol abusers.

Conclusion: TGF-beta 1 expression level can be a risk factor for alcoholic liver disease and might be related to the inflammatory activity and fibrosis of the liver in patients.

Citing Articles

Patterns of IgA Autoantibody Generation, Inflammatory Responses and Extracellular Matrix Metabolism in Patients with Alcohol Use Disorder.

Niemela O, Bloigu A, Bloigu R, Nivukoski U, Kultti J, Pohjasniemi H Int J Mol Sci. 2023; 24(17).

PMID: 37685930 PMC: 10487441. DOI: 10.3390/ijms241713124.

Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis.

Niu X, Zhu L, Xu Y, Zhang M, Hao Y, Ma L BMC Public Health. 2023; 23(1):859.

PMID: 37170239 PMC: 10173666. DOI: 10.1186/s12889-023-15749-x.

Ethanol sensitizes hepatocytes for TGF-β-triggered apoptosis.

Gaitantzi H, Meyer C, Rakoczy P, Thomas M, Wahl K, Wandrer F Cell Death Dis. 2018; 9(2):51.

PMID: 29352207 PMC: 5833779. DOI: 10.1038/s41419-017-0071-y.

Dynamic regulation of canonical TGFβ signalling by endothelial transcription factor ERG protects from liver fibrogenesis.

Dufton N, Peghaire C, Osuna-Almagro L, Raimondi C, Kalna V, Chauhan A Nat Commun. 2017; 8(1):895.

PMID: 29026072 PMC: 5638819. DOI: 10.1038/s41467-017-01169-0.

miR-217 regulates ethanol-induced hepatic inflammation by disrupting sirtuin 1-lipin-1 signaling.

Yin H, Liang X, Jogasuria A, Davidson N, You M Am J Pathol. 2015; 185(5):1286-96.

PMID: 25797648 PMC: 4419208. DOI: 10.1016/j.ajpath.2015.01.030.

References

Matsuoka M, Tsukamoto H . Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology. 1990; 11(4):599-605. DOI: 10.1002/hep.1840110412. View

Bedossa P, Peltier E, Terris B, Franco D, Poynard T . Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology. 1995; 21(3):760-6. View

Fan K . Regulatory effects of lipopolysaccharide in murine macrophage proliferation. World J Gastroenterol. 2002; 4(2):137-139. PMC: 4688635. DOI: 10.3748/wjg.v4.i2.137. View

Malizia G, Brunt E, Peters M, Rizzo A, Broekelmann T, McDonald J . Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology. 1995; 108(1):145-56. DOI: 10.1016/0016-5085(95)90019-5. View

Krull N, Zimmermann T, Gressner A . Spatial and temporal patterns of gene expression for the proteoglycans biglycan and decorin and for transforming growth factor-beta 1 revealed by in situ hybridization during experimentally induced liver fibrosis in the rat. Hepatology. 1993; 18(3):581-9. View

Roulot D, Durand H, Coste T, Rautureau J, Strosberg A, Benarous R . Quantitative analysis of transforming growth factor beta 1 messenger RNA in the liver of patients with chronic hepatitis C: absence of correlation between high levels and severity of disease. Hepatology. 1995; 21(2):298-304. View

Yang B, Li F . Quantitative analysis of TGF-alpha and EGFR mRNA in laryngeal carcinoma tissues. Chin Med J (Engl). 2001; 112(12):1088-92. View

Graham M, Bryson G, Diegelmann R . Transforming growth factor beta 1 selectively augments collagen synthesis by human intestinal smooth muscle cells. Gastroenterology. 1990; 99(2):447-53. DOI: 10.1016/0016-5085(90)91028-5. View

Fang C, Lindros K, Badger T, Ronis M, Ingelman-Sundberg M . Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole. Hepatology. 1998; 27(5):1304-10. DOI: 10.1002/hep.510270516. View

10.

Yokoyama H, Nagata S, Moriya S, Kato S, Ito T, KAMEGAYA K . Hepatic fibrosis produced in guinea pigs by chronic ethanol administration and immunization with acetaldehyde adducts. Hepatology. 1995; 21(5):1438-42. View

11.

Clot P, Parola M, Bellomo G, Dianzani U, Carini R, Tabone M . Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol. Gastroenterology. 1997; 113(1):265-76. DOI: 10.1016/s0016-5085(97)70104-5. View

12.

Raghow B, Irish P, Kang A . Coordinate regulation of transforming growth factor beta gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J Clin Invest. 1989; 84(6):1836-42. PMC: 304062. DOI: 10.1172/JCI114369. View

13.

Huang G, Zhang J, Zhang Y . Effects of retinoic acid on proliferation, phenotype and expression of cyclin-dependent kinase inhibitors in TGF-beta1-stimulated rat hepatic stellate cells. World J Gastroenterol. 2002; 6(6):819-823. PMC: 4728268. DOI: 10.3748/wjg.v6.i6.819. View

14.

Li C, Nanji A, Siakotos A, Lin R . Acetaldehyde-modified and 4-hydroxynonenal-modified proteins in the livers of rats with alcoholic liver disease. Hepatology. 1997; 26(3):650-7. DOI: 10.1002/hep.510260317. View

15.

Tuma D, Thiele G, Xu D, Klassen L, Sorrell M . Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology. 1996; 23(4):872-80. DOI: 10.1002/hep.510230431. View

16.

Milani S, Herbst H, Schuppan D, STEIN H, Surrenti C . Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol. 1991; 139(6):1221-9. PMC: 1886459. View

17.

Xu D, Thiele G, Beckenhauer J, Klassen L, Sorrell M, Tuma D . Detection of circulating antibodies to malondialdehyde-acetaldehyde adducts in ethanol-fed rats. Gastroenterology. 1998; 115(3):686-92. DOI: 10.1016/s0016-5085(98)70148-9. View

18.

Kamimura S, Tsukamoto H . Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology. 1995; 22(4 Pt 1):1304-9. View

19.

Czaja M, Weiner F, Flanders K, Giambrone M, Wind R, BIEMPICA L . In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J Cell Biol. 1989; 108(6):2477-82. PMC: 2115595. DOI: 10.1083/jcb.108.6.2477. View

20.

Israel Y . Antibodies against ethanol-derived protein adducts: pathogenic implications. Gastroenterology. 1997; 113(1):353-5. View